Literature DB >> 28962730

Differences in attractiveness comparing female profile modifications of Class II Division 1 malocclusion.

Aylin Gözde Yüksel1, Sebahat Yesim Iskender2, Reinder Kuitert2, Alexandra K Papadopoulou3, Kerem Dalci4, M Ali Darendeliler4, Oyku Dalci4.   

Abstract

INTRODUCTION: Our objective was to study the perceptions of laypeople for digital alterations and the amount of nasolabial angle increase that is tolerable and how much chin-neck length increase is needed to achieve a desirable profile in Class II Division 1 women with mandibular retrognathia.
METHODS: The profile image of a white woman with a Class II Division 1 mandibular rethrognatic profile was digitally modified to create 6 images: 3 with stepwise increased nasolabial angles of 113°, 121°, and 129°, and 3 with stepwise increased chin-neck distances of 51, 54, and 57 mm. These images were assessed and ranked by 155 white laypeople.
RESULTS: The baseline profile was judged significantly as the least attractive. A nasolabial angle of 129° was judged as unattractive as the baseline profile. Profiles with a chin-neck length of 54 and 57 mm were equally judged as most attractive.
CONCLUSIONS: The untreated (baseline) profile was found to be least esthetic, as well as the profile with the largest nasolabial angle. Nasolabial angle increases up to 121° seem to be acceptable. Profiles simulating a chin-neck length increase as produced by surgery seem to be most favored.
Copyright © 2017 American Association of Orthodontists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28962730     DOI: 10.1016/j.ajodo.2017.01.025

Source DB:  PubMed          Journal:  Am J Orthod Dentofacial Orthop        ISSN: 0889-5406            Impact factor:   2.650


  1 in total

1.  Aesthetic evaluation of the labiolingual position of maxillary lateral incisors by orthodontists and laypersons.

Authors:  Xue Jiang; Zhiwei Cao; Yang Yao; Zhihe Zhao; Wen Liao
Journal:  BMC Oral Health       Date:  2021-01-22       Impact factor: 2.757

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.